Review explores virulence factors and treatment options for carbapenem-resistant Acinetobacter baumannii, indicating significant public health concerns.
Key Points
Carbapenem-resistant Acinetobacter baumannii infections pose a major public health threat, linked to high resistance rates and limited treatment options.
Key virulence factors include capsular exopolysaccharide and efflux pumps, contributing to the pathogenicity observed in these infections.
Molecular analysis reveals resistance mechanisms involve production of carbapenemases like OXA-23 and metallo-β-lactamases such as VIM and NDM.
Recent treatment options combine older ligands like polymyxins with newer antimicrobials including eravacycline and cefiderocol, potentially improving outcomes.